1-3 March 2019, Penang, Malaysia
Positive Malaysian Treatment Access and Advocacy Group (MTAAG+), with partners Treatment Action Group and the Foundation for Innovative New Diagnostics, convened the first advocacy workshop on hepatitis C virus (HCV) diagnostics. The workshop presented the (...) More

Of the 71 million people living with chronic hepatitis C, only ≈20% are aware of their status and less than 5% of people living in LMICs have been diagnosed.
We need simpler & cheaper tests to scale up diagnosis! More

Advocates scandalized that Gilead’s hepatitis C profits have raked in US$25.8 billion, which could have treated everyone while still earning US$16 billion in profits.
6 December 2018, Paris, France, New York, NY— People living with hepatitis C, access to medicines activists, and the medical (...) More

Sign the pledge! If elimination by 2030 is to be achieved, the global community needs to act immediately. More

Geneva - July 2018
The World Health Organization released the updated Guidelines for the Care and Treatment of Persons Diagnosed with Chronic Hepatitis C Virus Infection. They follow and update the screening and care section of the WHO Guidelines for the screening, care and treatment of (...) More

This tutorial has been designed to help you as focal points (or mapCrowders) to enter data in the mapCrowd data fields related to a country that you agreed to inform. It will describe all the necessary steps to properly and easily fill in data.
General Tips / Section Epidemiological data / (...) More

Treatment Action Group (TAG) and Médecins du Monde are happy to announce the launch of mapCrowd 2.0! In this latest version, we added new options, this short document explains.
Let’s explore together the new feature of mapCrowd.2
Go to: www.mapcrowd.org You are landing on the public section (...) More